Synthesis and biological evaluation of N-[4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl]benzoyl]-L-glutamic acid as a potential inhibitor of GAR Tfase and the de novo purine biosynthetic pathway.
Heng Cheng, Inkyu Hwang, Youhoon Chong, Ali Tavassoli, Michael E Webb, Yan Zhang, Ian A Wilson, Stephen J Benkovic, Dale L Boger
Index: Bioorg. Med. Chem. 13(10) , 3593-9, (2005)
Full Text: HTML
Abstract
The synthesis and evaluation of N-[4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl]benzoyl]-L-glutamic acid (2) as an inhibitor of glycinamide ribonucleotide transformylase (GAR Tfase) and aminoimidazole carboxamide ribonucleotide transformylase (AICAR Tfase) are reported. The inhibitor 2 was prepared in a convergent synthesis involving C-alkylation of methyl 4-(4,4,4-trifluoro-3-dimethylhydrazonobutyl)benzoate with 1-chloro-3-iodopropane followed by construction of the pyrimidinone ring. Compound 2 was found to be an effective inhibitor of recombinant human GAR Tfase (K(i) = 0.50 microM), whereas it was inactive (K(i) > 100 microM) against E. coli GAR Tfase as well as recombinant human AICAR Tfase. Compound 2 exhibited modest, purine-sensitive growth inhibitory activity against the CCRF-CEM cell line (IC50 = 6.0 microM).
Related Compounds
Related Articles:
2011-01-07
[J. Org. Chem. 76(1) , 234-44, (2011)]
Synthesis of 1, 2, 3, 4-tetrahydroquinolines and 1, 2, 3, 4-tetrahydro-1, 6-naphthyridines by a directed lithiation reaction. Reed JN, et al.
[Tetrahedron Lett. 29(45) , 5725-28, (1988)]
Electrochemical Reduction of 1, 3-Dihalopropanes at Carbon Cathodes in Dimethylformamide. Pritts WA and Peters DG.
[J. Electrochem. Soc. 141(4) , 990-95, (1994)]
2007-08-31
[J. Org. Chem. 72 , 6961, (2007)]